Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel gene-agnostic therapies for patients suffering severe vision loss from retinal degenerative ...

Our eyes are one of the most important organs of our body, and not only are they our tool to see the outside world, but they can also be a reflection of our health. Changes in our eyes are not always ...

Regulatory Clearances Support Glaukos' Plans to Advance and Accelerate its Interventional Glaucoma Initiatives Globally Marks ...

New study shows cheap HIV drug lamivudine helps diabetic macular edema, improving vision. Oral option could replace eye ...

A recent study discovered that an inexpensive HIV drug could be effective for diabetic people by reversing a complication ...

Researchers have found in a phase 3 trial that phentolamine ophthalmic solution 0.75% led to significant improvements in ...

The drug, lamivudine, appears to improve vision that’s being threatened by diabetic macular edema (DME), an eye condition in ...

The global adaptive optics market revenue was around US$ 494.5 million in 2021 and is estimated to reach US$ 3846.5 billion by 2030, growing at a compound annual growth rate (CAGR) of 25.6% during the ...

Regular eye examinations are important components of a personal health regimen. Visiting an eye doctor can alert a person to ...

Global Ophthalmic Drugs Market is valued at approximately USD 38 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.10% over the forecast period 2024-2032. Read the ...

Eye emergencies—such as sudden vision loss, trauma, or severe eye pain—require immediate attention. While hospital ERs can ...

"Receiving the SMC recommendation of LYTENAVA™ (bevacizumab gamma) for patients with wet AMD is a significant milestone for our company and a testament to our commitment to improving patient outcomes, ...